# Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia

> **NCT00478179** · PHASE2 · COMPLETED · sponsor: **Durect** · enrollment: 60 (actual)

## Conditions studied

- Postherpetic Neuralgia
- Pain

## Interventions

- **DRUG:** Transdermal/Patch (Bupivacaine TTS [Eladur™])

## Key facts

- **NCT ID:** NCT00478179
- **Lead sponsor:** Durect
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2009-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478179, "Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00478179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*